Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab, A Case Report
Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine, incidence assessed by 18F FDG PET-CT and relevance to study interpretation
Immune Thrombotic Thrombocytopenic Purpura following Pfizer-BioNTech anti-COVID-19 vaccination in a patient healed from lymphoma after allogeneic hematopoietic stem cell transplantation